Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (6): 123-128.doi: 10.6040/j.issn.1673-3770.0.2021.323

• 综述 • Previous Articles    

Progress of cyclodestructive surgeries for treating glaucoma

LIU Lele, KONG XiangyunOverview,SHEN JiaquanGuidance   

  1. Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China
  • Published:2022-12-07

PDF (PC)

112

Abstract: Cyclodestruction is a kind of anti-glaucoma surgery that reduces intraocular pressure by damaging ciliary body to supress aqueous humor production in various ways, including cyclodiathermy, cyclocryotherapy, cyclophotocoagulation, photodynamic therapy of the ciliary body, and high-intensity focused ultrasound cycloplasty. In the past, it was considered as the last means to treat glaucoma and reduce intraocular pressure because of it's severe and serious complications and an unpredictable dose-effect relationship. With the development of medical technology, cyclodestructive surgeries have been greatly improved, intraocular pressure reduction become more effective, and the complications are significantly reduced and mild. It is a great progress in the history of anti-glaucoma surgery. This article introduces the characteristics, application, and progress of each type of cyclodestructive surgries.

Key words: Cyclodiathermy, Cyclocryotherapy, Cyclophotocoagulation, Photodynamic therapy of the ciliary body, High-intensity focused ultrasound cycloplasty, Glaucoma

CLC Number: 

  • R775
[1] 陶钰, 张士玺, 柴雪荣, 等. 青光眼患者生存质量及其影响因素的临床研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 84-86. doi: 10.6040/.j.issn.1673-3770.0.2014.037. TAO Yu, ZHANG Shixi, CHAI Xuerong, et al. Clinical study on glaucoma patients' quality of life and related factors[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2014, 28(2): 84-86. doi:10.6040/j.issn.1673-3770.0.2014.037.
[2] Jurjevic D, Funk J, Töteberg-Harms M. Zyklodestruktive Verfahren zur Senkung des Augeninnendrucks-eine übersicht[J]. Klin Monatsbl Augenheilkd, 2019, 236(1): 63-68. doi:10.1055/s-0043-105271.
[3] Abdullatif AM, Ahmed El-Saied HM. Various modalities of cyclodestruction in non-refractory glaucoma: a comparative study[J]. Int Ophthalmol, 2021, 41(10):3313-3323. doi:10.1007/s10792-021-01893-z.
[4] Vogt A. Cyclodiathermypuncture in cases of glaucoma[J]. Br J Ophthalmol. 1940, 24(6): 288-297. doi:10.1136/bjo.24.6.288.
[5] Urrets-zavalia A Jr, Urrets-zavalia A. Nonperforating cyclodiathermy in the treatment of glaucoma; diathermia retrociliaris[J]. Am J Ophthalmol, 1953, 36(2): 203-217. doi:10.1016/0002-9394(53)90899-x.
[6] Bietti G. Surgical intervention on the ciliary body[J]. J Am Med Assoc, 1950, 142(12): 889. doi:10.1001/jama.1950.02910300027006.
[7] Dastiridou AI, Katsanos A, Denis P, et al. Cyclodestructive procedures in glaucoma: a review of current and emerging options[J]. Adv Ther, 2018, 35(12): 2103-2127. doi:10.1007/s12325-018-0837-3.
[8] Caprioli J, Strang SL, Spaeth GL, et al. Cyclocryotherapy in the treatment of advanced Glaucoma[J]. Ophthalmology, 1985, 92(7): 947-954. doi:10.1016/s0161-6420(85)33951-9.
[9] 郭娟. 睫状体冷凝手术治疗各型晚期青光眼[J]. 眼外伤职业眼病杂志, 2003(10): 662-663. doi: CNKI:SUN:YWSZ.0.2003-10-008. GUO Juan. Treatment of late-stage Glaucoma by cyclocryotherapy[J]. Chin J Ocular Trauma Occup Eye Dis Ophthalmic Surg, 2003(10): 662-663. doi: CNKI:SUN:YWSZ.0.2003-10-008.
[10] Devenyi RG, Trope GE, Hunter WH, et al. Neodymium: YAG transscleral cyclocoagulation in human eyes[J]. Ophthalmology, 1987, 94(12):1519-1522. doi:10.1016/s0161-6420(87)33252-x.
[11] Zimmerman TJ, Worthen DM, Wickham G. Argon laser photocoagulation of ciliary processes and pigmented pupillary membrane in man[J]. Invest Ophthalmol, 1973, 12(8): 622-623. doi: 10.1016/0014-4835(73)90009-2.
[12] Devenyi RG, Trope GE, Hunter WH, et al. Neodymium: YAG transscleral cyclocoagulation in human eyes[J]. Ophthalmology. 1987, 94(12): 1519-1522. doi:10.1016/s0161-6420(87)33252-x.
[13] Hennis HL, Stewart WC. Semiconductor diode laser transscleral cyclophotocoagulation in patients with Glaucoma[J]. Am J Ophthalmol, 1992, 113(1): 81-85. doi:10.1016/s0002-9394(14)75758-7.
[14] Iliev ME, Gerber S. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory Glaucoma[J]. Br J Ophthalmol, 2007, 91(12): 1631-1635. doi:10.1136/bjo.2007.116533.
[15] 侯旭, 武静, 周健, 等. 以个体化透巩膜睫状体光凝为首选术式治疗钝挫伤后青光眼眼压失控的安全性和有效性[J]. 临床医学研究与实践, 2020, 5(31): 7-10. doi:10.19347/j.cnki.2096-1413.202031002. HOU Xu, WU Jing, ZHOU Jian, et al. Safety and effectiveness of individualized transscleral cyclophotocoagulation as the initial surgical intervention for medically uncontrolled intraocular pressure in Glaucoma after blunt trauma[J]. Clin Res Pract, 2020, 5(31): 7-10. doi:10.19347/j.cnki.2096-1413.202031002.
[16] Chiam PJ, Sung VCT. The outcome of transscleral cyclophotocoagulation for the management of acute angle closure[J]. Eur J Ophthalmol, 2018, 28(2): 188-192. doi:10.5301/ejo.5001026.
[17] Abdullatif AM, Ahmed El-Saied HM. Various modalities of cyclodestruction in non-refractory glaucoma: a comparative study[J]. Int Ophthalmol, 2021, 41(10): 3313-3323. doi:10.1007/s10792-021-01893-z.
[18] 田丹丹, 李晶明, 宋艳敏, 等. 巩膜睫状体光凝术治疗恶性青光眼睫状环阻滞解除后高眼压[J]. 国际眼科杂志, 2021, 21(2): 348-350. doi: 10.3980/j.issn.1672-5123.2021.2.32. TIAN Dandan, LI Jingming, SONG Yanmin, et al. Clinical observation of high intraocular pressure after the removal of ciliary ring block in the treatment of malignant Glaucoma by scleral cyclophotocoagulation[J]. Int Eye Sci, 2021, 21(2): 348-350. doi: 10.3980/j.issn.1672-5123.2021.2.32.
[19] Sieminski SF, Varikuti VNV, Shah P, et al. Response to: outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision[J]. J Glaucoma, 2020, 29(3): e16-e17. doi:10.1097/IJG.0000000000001437.
[20] Kosoko O, Gaasterland DE, Pollack IP, et al. Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group[J]. Ophthalmology, 1996, 103(8): 1294-1302. doi:10.1016/s0161-6420(96)30508-3.
[21] Uram M. Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular Glaucoma[J]. Ophthalmology, 1992, 99(12): 1823-1828. doi:10.1016/s0161-6420(92)31718-x.
[22] Pantcheva MB, Kahook MY, Schuman JS, et al. Comparison of acute structural and histopathological changes of the porcine ciliary processes after endoscopic cyclophotocoagulation and transscleral cyclophotocoagulation[J]. Clin Exp Ophthalmol, 2007, 35(3): 270-274. doi:10.1111/j.1442-9071.2006.01415.x.
[23] Yu MB, Huang SS, Ge J, et al. The clinical study of endoscopic cyclophotocoagulation on the management of refractory glaucoma[J]. Zhonghua Yan Ke Za Zhi, 2006, 42(1): 27-31. doi: 10.1109/ECTC.2008.4550264.
[24] Wicek MP, Miszczuk T, Lipiński A, et al. Safety and efficacy of isolated endoscopic cyclophotocoagulation in pseudophakic patients with primary open-angle glaucoma-12-month follow-up[J]. J Clin Med, 2021, 10(18): 4212. doi:10.3390/jcm10184212.
[25] Feinstein MA, Lee JH, Amoozgar B, et al. Comparison between pars Plana and anterior endoscopic cyclophotocoagulation for the treatment of Glaucoma[J]. Clin Exp Ophthalmol, 2019, 47(6): 766-773. doi:10.1111/ceo.13501.
[26] Waldo LG, Julio HQ, Jennifer CV, et al. Combined technique for the application of micropulse cyclophotocoagulation in patients with uncontrolled glaucoma: cyclo mix[J]. J Curr Glaucoma Pract, 2020, 14(3): 93-97. doi:10.5005/jp-journals-10078-1289.
[27] Kuchar S, Moster MR, Reamer CB, et al. Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced Glaucoma[J]. Lasers Med Sci, 2016, 31(2): 393-396. doi:10.1007/s10103-015-1856-9.
[28] Fea AM, Laffi GL, Martini E, et al. Effectiveness of MicroShunt in patients with primary open-angle and pseudoexfoliative glaucoma: a retrospective European multicenter study[J]. Ophthalmol Glaucoma, 2021, 5(2):210-218. doi:10.1016/j.ogla.2021.08.005.
[29] Nguyen AT, Maslin J, Noecker RJ. Early results of micropulse transscleral cyclophotocoagulation for the treatment of Glaucoma[J]. Eur J Ophthalmol, 2020, 30(4): 700-705. doi:10.1177/1120672119839303.
[30] Hill RA, Esterowitz T, Ryan J, et al. Photodynamic laser cyclodestruction with chloroaluminum sulfonated phthalocyanine(CASPc)or Photofrin(PII)vs. Nd: YAG laser cyclodestruction in a pigmented rabbit model[J]. Lasers Surg Med, 1995, 17(2): 166-171. doi:10.1002/lsm.1900170205.
[31] Charisis SK, Detorakis ET, Vitanova VS, et al. Contact transcleral photodynamic cyclo-suppression in human eyes: a feasibility study[J]. Can J Ophthalmol, 2011, 46(2): 196-198. doi:10.3129/i10-109.
[32] Lynn JG, Zwemer RL, Chick AJ, et al. A new method for the generation and use of focused ultrasound in experimental biology[J]. J Gen Physiol, 1942, 26(2): 179-193. doi:10.1085/jgp.26.2.179.
[33] Coleman DJ, Lizzi FL, Driller J, et al. Therapeutic ultrasound in the treatment of glaucoma II. Clinical applications[J]. Ophthalmology, 1985, 92(3):347-353. doi: 10.1016/S0161-6420(85)34028-9.
[34] Aptel F, Charrel T, Palazzi X, et al. Histologic effects of a new device for high-intensity focused ultrasound cyclocoagulation[J]. Invest Ophthalmol Vis Sci, 2010, 51(10): 5092-5098. doi:10.1167/iovs.09-5135.
[35] Mastropasqua R, Agnifili L, Fasanella V, et al. Uveo-scleral outflow pathways after ultrasonic cyclocoagulation in refractory glaucoma: an anterior segment optical coherence tomography and in vivo confocal study[J]. Br J Ophthalmol, 2016, 100(12): 1668-1675. doi:10.1136/bjophthalmol-2015-308069.
[36] Morais Sarmento T, Figueiredo R, Garrido J, et al. Transient choroidal detachment after ultrasonic circular cyclocoagulation[J]. BMJ Case Rep, 2019, 12(10): e231677. doi:10.1136/bcr-2019-231677.
[37] 牟大鹏, 唐炘, 安文在, 等. 超声睫状体成形术治疗难治性青光眼半年随访效果的临床研究[J]. 中华眼科医学杂志(电子版), 2019, 9(6): 366-371. doi: CNKI:SUN:ZHYB.0.2019-06-008. MOU Dapeng, TANG Xin, AN Wenzai, et al. Half-year follow-up of ultrasound cycloplasty for refractory Glaucoma[J]. Chin J Ophthalmol Med Electron Ed, 2019, 9(6): 366-371. doi: CNKI:SUN:ZHYB.0.2019-06-008.
[38] 夏冉, 姜波, 王明睿, 等. 超声睫状体成形术治疗新生血管性青光眼短期疗效观察[J]. 临床眼科杂志, 2021, 29(2): 157-160. doi: 10.3969/j.issn.1006-8422.2021.02.014. XIA Ran, JIANG Bo, WANG Mingrui, et al. Therapeutic effect of ultrasound cycloplasty on neovascular Glaucoma[J]. J Clin Ophthalmol, 2021, 29(2): 157-160. doi: 10.3969/j.issn.1006-8422.2021.02.014.
[39] Giannaccare G, Pellegrini M, Bernabei F, et al. A 2-year prospective multicenter study of ultrasound cyclo plasty for Glaucoma[J]. Sci Rep, 2021, 11(1): 12647. doi:10.1038/s41598-021-92233-9.
[40] Rouland JF, Aptel F. Efficacy and safety of ultrasound cycloplasty for refractory glaucoma: a 3-year study[J]. J Glaucoma, 2021, 30(5): 428-435. doi:10.1097/IJG.0000000000001796.
[41] De Gregorio A, Pedrotti E, Stevan G, et al. Safety and efficacy of multiple cyclocoagulation of ciliary bodies by high-intensity focused ultrasound in patients with Glaucoma[J]. Graefes Arch Clin Exp Ophthalmol, 2017, 255(12): 2429-2435. doi:10.1007/s00417-017-3817-4.
[42] Hu D, Tu S, Zuo C, et al. Short-term observation of ultrasonic cyclocoagulation in Chinese patients with end-stage refractory glaucoma: a retrospective study[J]. J Ophthalmol, 2018: 4950318. doi:10.1155/2018/4950318.
[43] Yu QL, Liang Y, Ji FF, et al. Comparison of ultrasound cycloplasty and transscleral cyclophotocoagulation for refractory Glaucoma in Chinese population[J]. BMC Ophthalmol, 2020, 20(1): 387. doi:10.1186/s12886-020-01655-y.
[1] SHI Boying, LIANG Hao, LI Yihong, TANG Dongyong. Surgical treatment of a cataract complicated by anti-glaucoma surgery in an adult patient with Blau syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 60-65.
[2] TANG Feiran, KONG XiangyunOverview,SHEN JiaquanGuidance. Research progress in the role of OCTA in measuring superficial peripapillary vessel density in the diagnosis and treatment of glaucoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 77-82.
[3] ZHAO Ying, ZHANG ShanOverview,XU Jiajun, ZHAO JingruGuidance. Research progress on the protective mechanism of heat shock protein 72 in glaucoma retinal ganglion cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 83-87.
[4] ObjectiveTo discuss the causes and appropriate treatment for iris neovascularization following the analysis of cases( eyes). MethodsIt was a retrospective case series study involving patients( eyes)with iris neovascularization diagnosed between September and July . All the patients underwent ophthalmic examination, and all the examination findings and treatments were recorded. The causes, correlative factors, and treatment outcomes of iris neovascularization were analyzed. ResultsOf the patients, ( eyes, .%)had retinal ischemic signs, including vitreous hemorrhage and retinal vascularization on fundus fluorescein angiography, ( eyes, .%)did not have retinal ischemic signs. After months of treatment, retinal vascularization resolved in all the cases, and iris neovascularization resolved completely in patients( eyes, .%), iris neovascularization was still found in patients( eyes, .%). ConclusionsAnterior segment ischemia may also lead to iris vascularization, although retinal ischemia was the main cause. Additionally, iris neovascularization may not always resolve with treatment for retinal ischemia. Finally, anti-VEGF drug injection was an effective treatment for iris neovascularization.. Case analysis of 25 cases of iris neovascularizationLI Xuan1,2, HUANG Yingxiang2 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; 2. Department of Fundus Disease and Eye Trauma, Eye Hospital China Academy of Chinese Medicine Sciences, Beijing 100040, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 41-47.
[5] ObjectiveTo discuss the early diagnosis and multidisciplinary diagnosis and treatment of neovascular glaucoma in ocular ischemic syndrome. MethodsThe medical records of a 54-year-old male patient with cerebral infarction who presented with right-eye vision loss that had persisted for a week were reviewed. After slit-lamp examination and fluorescence angiography, he was diagnosed with ocular ischemic syndrome(OIS)complicated by neovascular glaucoma in the right eye and treated with intravitreal injection of anti-VEGF drugs and panretinal photocoagulation. ResultsAfter three months of treatment, the right-eye iris neovascularization subsided, and the intraocular pressure was controlled within normal limits. ConclusionOcular ischemia is often missed or misdiagnosed by ophthalmologists, neurologists, cardiologists, and vascular surgeons due to its insidious onset and complex clinical manifestations. Therefore, the establishment of multidisciplinary diagnosis and treatment can improve the prognosis of OIS patients.. Neovascular glaucoma in ocular ischemic syndrome: a case report and literature reviewQIN Shuqi1, WANG Luping1, JIANG Bin2, WANG Yanling1 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, China; 2. Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 53-55.
[6] Ruibao LIU,Ying ZHAO,Minglu GUO,Yu DUAN,Yanxia WU,Xuejing LU. Autophagy and its research progress in glaucoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 158-161.
[7] LIU Lin, ZHENG Hua, CHEN Shaolin, DUAN Xuanchu. Neuroprotective effects and safety of stem cell transplantation in rats with experimental glaucoma: a systematic review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 138-144.
[8] TENG Xingbo, CAO Zhi, SUN Haixia, LIU Xianjin, YANGa Weizhou, ZHU Yan, ZHU Yuguang. Role of GRP94 and EIF2α in trabecular bone of primary angle-closure glaucoma patients [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 115-118.
[9] XIE Hongbin, YANG Meina, CHEN Qingshan, LIU Xuyang, FAN Ning. Analysis of immunoglobulin G4-related ophthalmic disease associated with secondary glaucoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 99-102.
[10] GAO Xue, HAO Linlin, LIU Shaohua, ZHANG Han. Comparison of two intraocular lens measurement formulas for prediction of postoperative refraction accuracy in patients with angle closure glaucoma and cataract [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 68-71.
[11] XU Xiao. Clinical observations of Ex-PRESS glaucoma filtration device implantation in patients with glaucoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 90-93.
[12] . Efficacy and safety of EX-PRESS implanation versus trabeculectomy for open-angle glaucoma: a meta-analysis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 104-111.
[13] . The aqueous levels of TNF-α and IP-10 in different kinds of glaucoma and their correlation. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(1): 103-106.
[14] YANG Hongling. Research advances on the assessment and influencing factors of glaucoma patients’ quality of life. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(6): 94-97.
[15] LI Dongmei. Influence of long-term use of prostaglandin drugs on meibomian gland function and corneal structure in patients with primary open angle glaucoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(3): 89-92.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd